There "should" be news on first patient dose in burns trial, assuming they chose to announce that after suggesting it would take place in Q1. Surely we are very close to that now. Earlier update suggested data may be available on first patient by end q1 so must be starting soon.
from last 4c
Operational Highlights HREC Approval for Burns Wounds Study Human Research Ethics Committee approval to start a Phase I/II clinical trial of broad- spectrum antibiotic R327 on patients with infected burns wounds was received during the quarter. The study site has been identified as Fiona Stanley Hospital’s Burn Unit in Perth, Western Australia and is anticipated to be sponsored by the South Metropolitan Health Service, Department of Health, Government of Western Australia. The study will asses safety and efficacy of R327 on up to 30 patients with Gram-positive and Gram-negative bacterial burn wound infections and first patient data is expected to be available Q1 2021.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)